Ali Muhadisa, Salim Saad Y, Sheikh Fatima, Fox-Robichaud Alison E
Faculty of Health Science, McMaster University, Hamilton, Ontario, Canada.
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
PLOS Glob Public Health. 2025 Apr 29;5(4):e0003606. doi: 10.1371/journal.pgph.0003606. eCollection 2025.
Sepsis is the world's second leading cause of mortality. In 2017, the World Health Assembly declared sepsis a global priority and adopted a resolution prompting member states to improve the prevention, recognition, and management of sepsis. This cross-sectional study examines the sepsis research landscape in Canada, including demographics, scope, and funding. Using convenient sampling, sepsis researchers in Canada were asked to complete an online 20-question survey. We also scanned the CIHR funding database from 2012-2022 to quantify national research dollars spent on sepsis-related projects. Quantitative data was summarized using descriptive statistics, and textual descriptions of current sepsis research activities were analyzed thematically. With a response rate of 46% (69 of the 150), respondents were primarily men (n = 46/69, 67%), who identified as White/European (n = 49/69, 71%), and were professors or clinical professors (n = 36/69, 52%). The predominant areas of research focus were identification of sepsis (n = 21/55, 38%) and treatment/management (29/55, 53%) of sepsis, while sepsis prevention (n = 4/55, 7%) and sepsis education (n = 5/55, 9%) garnered less attention. Past 10 years of CIHR funding data revealed that only 0.7% ($85 million) of total funding ($11 billion) was towards sepsis research, of which only 2 were new-investigator awards. This study illustrates the need for improving the diversity of sepsis researchers in Canada; expanding the scope of research to address sepsis prevention, recovery, and education; and increasing overall funding to sepsis.
脓毒症是全球第二大致死原因。2017年,世界卫生大会宣布脓毒症为全球重点问题,并通过了一项决议,促使成员国改善脓毒症的预防、识别和管理。这项横断面研究考察了加拿大的脓毒症研究状况,包括人口统计学特征、研究范围和资金情况。采用便利抽样的方法,邀请加拿大的脓毒症研究人员完成一项包含20个问题的在线调查问卷。我们还扫描了2012年至2022年加拿大卫生研究院(CIHR)的资助数据库,以量化用于脓毒症相关项目的国家研究资金。定量数据采用描述性统计进行总结,对当前脓毒症研究活动的文字描述进行了主题分析。回复率为46%(150人中69人回复),受访者主要为男性(n = 46/69,67%),自我认定为白人/欧洲人(n = 49/69,71%),且为教授或临床教授(n = 36/69,52%)。研究重点的主要领域是脓毒症的识别(n = 21/55,38%)和脓毒症的治疗/管理(29/55,53%),而脓毒症的预防(n = 4/55,7%)和脓毒症教育(n = 5/55,9%)受到的关注较少。过去10年加拿大卫生研究院的资助数据显示,在总资助金额(110亿美元)中,仅有0.7%(8500万美元)用于脓毒症研究,其中只有2项是新研究者奖。这项研究表明,加拿大需要提高脓毒症研究人员的多样性;扩大研究范围以解决脓毒症的预防、康复和教育问题;并增加对脓毒症研究的总体资助。